New gene therapy aims to slow vision loss in rare eye disease
Disease control
Recruiting now
This study tests a one-time gene therapy injection into the eye for people with advanced retinitis pigmentosa caused by mutations in the RHO, PDE6A, or PDE6B genes. The goal is to see if it is safe and can slow vision loss. About 33 adults will take part, and the study will follo…
Phase: PHASE1, PHASE2 • Sponsor: SparingVision • Aim: Disease control
Last updated May 11, 2026 20:48 UTC